RedHill Biopharma raises maximum size of ATM ADS offering under H.C. Wainwright agreement
RDHL•RedHill Biopharma filed a prospectus supplement raising the maximum aggregate amount of ADSs it may sell through its at-the-market offering under an equity distribution agreement with H.C. Wainwright.
1. Offering supplement
RedHill Biopharma filed a prospectus supplement raising the maximum aggregate amount of ADSs it may sell from time to time under an equity distribution agreement with H.C. Wainwright, entered on Feb. 3, 2025. Each ADS represents 10,000 ordinary shares.
